Daniel Brownell

Director, Research & Development at AOBiome Therapeutics

Daniel Brownell currently serve as the Director of R&D at AOBiome, responsible for preclinical research, study execution, and clinical support. Previously, he have served as the Director of R&D and Manufacturing at Sample6, who developed a line of rapid diagnostics for the food safety industry.


Title: Ammonia Oxidizing Bacteria as a Treatment for Inflammatory Skin Disease

  • Background information of AOBiome
  • Mechanisms of Action of Ammonia Oxidizing Bacteria
  • Clinical Trials using Ammonia Oxidizing Bacteria